{"id":820477,"date":"2025-03-03T08:27:25","date_gmt":"2025-03-03T13:27:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/"},"modified":"2025-03-03T08:27:25","modified_gmt":"2025-03-03T13:27:25","slug":"connect-biopharma-to-present-at-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/","title":{"rendered":"Connect Biopharma to Present at Two Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, March  03, 2025  (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB) (\u201cConnect Biopharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), today announced that company management will participate in the following upcoming conferences:<\/p>\n<p align=\"justify\">\n        <strong>Leerink Partners Global Biopharma Conference<\/strong><br \/>\n        <br \/>Format:\u00a0Fireside Chat<br \/>Date: Wednesday, March 12, 2025<br \/>Time: 1:40 p.m. ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wx0DpogobkCzvpZ4V1HhR_CeHhGdjaMTXIYDGZcOFcm0qTuvVrYWANQcR7G2JIPREW-4SFhCaGmwbro3QETZvxbPLERRr1krTsSlB1wvVrn4fdR82p1ujoU8JxpIKLJF\" rel=\"nofollow\" target=\"_blank\">Register Here<\/a><\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright 3<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Autoimmune &amp; Inflammatory Disease Virtual Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat<br \/>Date: Thursday, March 27, 2025<br \/>Time: 2:30 p.m. ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wx0DpogobkCzvpZ4V1HhRyC65HhGUQ8jZ3O460qUCdrWH2gilCOgCVOmOSztrsjxVR1G7Fta83t6nKu_PFUewsNoQ7UBa0ueMR8IeRPkIciLL3P8E-pECB4OKixKsjte9OcMfgbJqxCsEYYAwXsrHg==\" rel=\"nofollow\" target=\"_blank\">Register Here<\/a><\/p>\n<p align=\"justify\">Live webcasts for the\u00a0events will also be accessible on Connect\u2019s website in the Investors section under Presentations, Events &amp; News at\u00a0 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yGJ_uEvmO2QvE1tLOvSBCGI0yvnJlMdNAzmznOFuERhW6GYNhoV6qRWX1Jpzv_4PVL3DLZ1Ap_0wmNO0fTa15DxEyPPJJ73zY41FkfTiJBQYIRffsHDL6_LI80hHLspP\" rel=\"nofollow\" target=\"_blank\">investors.connectbiopharm.com<\/a>. An archived replay of the webcasts will be available for approximately 90 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Connect Biopharma<\/strong><br \/>\n        <br \/>Connect Biopharma, headquartered in San Diego, California, is a clinical-stage biopharmaceutical company focused on advancing Rademikibart\u2122, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4R\u03b1) antibody, to transform care in Asthma and COPD. Rademikibart has the potential to drive significant chronic utilization in Asthma and COPD with an initial focus on acute indications, which represent an untapped opportunity targeting the ~1 million asthma and ~1.3 million COPD patients in the U.S. alone who experience acute exacerbations annually. Rademikibart has demonstrated encouraging efficacy and safety in Phase 2 studies, as well as rapid onset of action as early as 24 hours. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HF1YJQoory5UVTIhQSnKI_bMgrvg7USFGIDFiWreAgeTcanxFyiFU9O2eTf6sVvkhliPMJkvopFM_sZx7aMVh3p0J0JmIzf_hCS0LZkY1dw=\" rel=\"nofollow\" target=\"_blank\">www.connectbiopharm.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations &amp; Media Contact: <\/strong><br \/>\n        <br \/>David Szekeres <br \/>President <br \/>Connect Biopharma<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sQ6jRWU0fiQgvC29tTtTMRXG8KzBpDj_MLFZiaW6kN9KOptM66nzJg6Xpijc0v9D5CUd-iS-v87JyvlhvPvIVaL7Z3aya1Rz5qqRW0iut8cURcohH8pnkwGQuiaebCGz\" rel=\"nofollow\" target=\"_blank\">dszekeres@connectpharm.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzQ5MzYwMTItZjAyYS00MGU3LTg1NDktZGFkMzdjYWYwZTNjLTEyMTkwNjQ=\/tiny\/Connect-Biopharma-Holdings-Lim.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB) (\u201cConnect Biopharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), today announced that company management will participate in the following upcoming conferences: Leerink Partners Global Biopharma Conference Format:\u00a0Fireside ChatDate: Wednesday, March 12, 2025Time: 1:40 p.m. ETWebcast Link: Register Here H.C. Wainwright 3 rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference Format: Fireside ChatDate: Thursday, March 27, 2025Time: 2:30 p.m. ETWebcast Link: Register Here Live webcasts for the\u00a0events will also be accessible on Connect\u2019s website in the Investors section under Presentations, Events &amp; News at\u00a0 investors.connectbiopharm.com. An archived replay of the webcasts will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Connect Biopharma to Present at Two Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-820477","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB) (\u201cConnect Biopharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), today announced that company management will participate in the following upcoming conferences: Leerink Partners Global Biopharma Conference Format:\u00a0Fireside ChatDate: Wednesday, March 12, 2025Time: 1:40 p.m. ETWebcast Link: Register Here H.C. Wainwright 3 rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference Format: Fireside ChatDate: Thursday, March 27, 2025Time: 2:30 p.m. ETWebcast Link: Register Here Live webcasts for the\u00a0events will also be accessible on Connect\u2019s website in the Investors section under Presentations, Events &amp; News at\u00a0 investors.connectbiopharm.com. An archived replay of the webcasts will &hellip; Continue reading &quot;Connect Biopharma to Present at Two Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T13:27:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Connect Biopharma to Present at Two Upcoming Investor Conferences\",\"datePublished\":\"2025-03-03T13:27:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/\"},\"wordCount\":258,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/\",\"name\":\"Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\",\"datePublished\":\"2025-03-03T13:27:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Connect Biopharma to Present at Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB) (\u201cConnect Biopharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), today announced that company management will participate in the following upcoming conferences: Leerink Partners Global Biopharma Conference Format:\u00a0Fireside ChatDate: Wednesday, March 12, 2025Time: 1:40 p.m. ETWebcast Link: Register Here H.C. Wainwright 3 rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference Format: Fireside ChatDate: Thursday, March 27, 2025Time: 2:30 p.m. ETWebcast Link: Register Here Live webcasts for the\u00a0events will also be accessible on Connect\u2019s website in the Investors section under Presentations, Events &amp; News at\u00a0 investors.connectbiopharm.com. An archived replay of the webcasts will &hellip; Continue reading \"Connect Biopharma to Present at Two Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-03T13:27:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Connect Biopharma to Present at Two Upcoming Investor Conferences","datePublished":"2025-03-03T13:27:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/"},"wordCount":258,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/","name":"Connect Biopharma to Present at Two Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=","datePublished":"2025-03-03T13:27:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzE1OSM2NzgxMDYwIzIyMDc1MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Connect Biopharma to Present at Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=820477"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=820477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=820477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=820477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}